Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA85A Vaccine for TB in HIV-Infected Adults
NCT01151189Phase 2Completed
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- Jul 2011
- Primary completion
- May 2014
- Modality
- Viral Vector Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of MVA85A in Tuberculosis (TB), sponsored by Aeras Global Vaccine Foundation. Started Jul 2011; status: completed.
02
Drugs
MVA85A
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01151189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01151189.